Browsing by Author Holz, Frank

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 9 of 9
Issue DateTitleAuthor(s)Citation
2012Age-related macular degenerationMitchell, Paul (Ronald); Holz, Frank; Lim, Laurence; Seddon, Johanna; Wong, Tien Yin; Western Clinical School: Westmead Millennium InstituteAge-related macular degeneration, The Lancet, vol.379, 9827, 2012,pp 1728-1738
2010Analysis of glutathione S-transferase Pi isoform (GSTP1) single-nucleotide polymorphisms and macular telangiectasia type 2Gillies, Mark; Amirul Islam, F. M.; Baird, Paul Nigel; Guymer, Robyn; Holz, Frank; Issa, Peter Charbel; Richardson, Andrea Jane; Scholl, Hendrik P. N.; Szental, Joshua A; Central Clinical School: Save Sight & Eye Health Inst.Analysis of glutathione S-transferase Pi isoform (GSTP1) single-nucleotide polymorphisms and macular telangiectasia type 2, International Ophthalmology, vol.30, 6,pp 645-650
2010The effects of a flexible visual acuity-driven ranibizumab treatment regimen in age-related macular degeneration: outcomes of a drug and disease modelMitchell, Paul (Ronald); Holz, Frank; Korobelnik, J-F; Lanzetta, P; Markabi, Sabri; Schmidli, Heinz; Schmidt-Erfurth, U; Weichselberger, Andreas; Wolf, Sebastian; Western Clinical School: Westmead Millennium InstituteThe effects of a flexible visual acuity-driven ranibizumab treatment regimen in age-related macular degeneration: outcomes of a drug and disease model, Investigative Ophthalmology & Visual Science, vol.51, 1,pp 405-412
2009Familial Asymptomatic Macular Telangiectasia Type 2Ali, Haipha; Gillies, Mark; Hughes, Edward; Zhu, Meidong; Barthelmes, Daniel; Chew, Emily Y; Holz, Frank; Issa, Peter Charbel; Scholl, Hendrik; Central Clinical School: Save Sight & Eye Health Inst.; Central Clinical School: Save Sight & Eye Health Inst.; Central Clinical School: Save Sight & Eye Health Inst.; Central Clinical School: Save Sight & Eye Health Inst.Familial Asymptomatic Macular Telangiectasia Type 2, Ophthalmology: journal of the American Academy of Ophthalmology, vol.116, 12,pp 2422-2429
2013Macular telangiectasia type 2Gillies, Mark; Bird, Alan C.; Chew, Emily Y; Heeren, Tjebo F.C.; Holz, Frank; Issa, Peter Charbel; Peto, Tunde; Scholl, Hendrik P. N.; Central Clinical School: Save Sight & Eye Health Inst.Macular telangiectasia type 2, Progress in Retinal and Eye Research, vol.34, N/A, 2013,pp 49-77
2010Ranibizumab (Lucentis) in neovascular age-related macular degeneration: evidence from clinical trialsMitchell, Paul (Ronald); Holz, Frank; Korobelnik, J-F; Lanzetta, P; Prunte, C; Schmidt-Erfurth, U; Tano, Yasuo; Wolf, S; Western Clinical School: Westmead Millennium InstituteRanibizumab (Lucentis) in neovascular age-related macular degeneration: evidence from clinical trials, British Journal of Ophthalmology, vol.94, N/A,pp 2-13
2013Safety of ranibizumab in routine clinical practice: 1-year retrospective pooled analysis of four European neovascular AMD registries within the LUMINOUS programmeGillies, Mark; Mitchell, Paul; Bandello, Francesco; Figueroa, Marta S; Holz, Frank; Osborne, Aaron; Sheidow, Tom; Souied, Eric; Central Clinical School: Save Sight & Eye Health Inst.; Western Clinical School: Westmead Millennium InstituteSafety of ranibizumab in routine clinical practice: 1-year retrospective pooled analysis of four European neovascular AMD registries within the LUMINOUS programme, The British Journal of Ophthalmology, vol.97, 9, 2013,pp 1161-1167
2014Three-Year Outcomes of Individual Ranibizumab Treatment in Patients with Diabetic Macular Edema. The RESTORE Extension StudyMitchell, Paul; Bouazza, Abdelkader Si; Gerstner, Ortrud; Holz, Frank; Lang, Gabriele E.; Lanzetta, P; Massin, Pascale; Osborne, Aaron; Schlingemann, Reinier O.; Schmidt-Erfurth, U; Shen, Haige; Western Clinical School: Westmead Millennium InstituteThree-Year Outcomes of Individual Ranibizumab Treatment in Patients with Diabetic Macular Edema. The RESTORE Extension Study, Ophthalmology, vol.121, 5, 2014,pp 1045-1053
2013Two-year safety and efficacy of ranibizumab 0.5 mg in diabetic macular edema: Interim analysis of the RESTORE extension studyMitchell, Paul; Berta, Andras; Eldem, Bora M.; Gerstner, Ortrud; Holz, Frank; Lang, Gabriele E.; Sharp, Dianne; Simader, Christian; Sutter, Florian; Western Clinical School: Westmead Millennium InstituteTwo-year safety and efficacy of ranibizumab 0.5 mg in diabetic macular edema: Interim analysis of the RESTORE extension study, Ophthalmology, vol.120, 10, 2013,pp 2004-2012